menu search

Longeveron Files Registration Statement for Rights Offering

Longeveron Files Registration Statement for Rights Offering
MIAMI, June 27, 2023 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as Alzheimer’s Disease and Aging Frailty, announced today that it has filed a registration statement with the Securities and Exchange Commission (“SEC”) to conduct a tradeable […] The post Longeveron Files Registration Statement for Rights Offering appeared first on F... Read More
Posted: Jun 27 2023, 22:07
Author Name: forextv
Views: 101962

Search within

Pages Search Results: